NAPWA

Treataware activities for 2012 are currently in planning.

Treataware organises Chin Wag events and Short Courses in HIV Medicine for Community and Industry, as well producing resources and factsheets on HIV care and treatments. read more »

Melbourne-based biotech Avexa has announced the closure of its lead HIV program for apricitabine after failing to attract a licensing partner for the Phase IIIA large clinical trialA clinical trial is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase I tests a new drug or treatment in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people; and Phase IV takes place after the drug or treatment has been licensed and marketed. designed to establish whether a drug is effective and safe enough for widespread use. Phase III studies include expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness(Of a drug or treatment). The maximum ability of a drug or treatment to produce a result regardless of dosage. A drug passes efficacy trials if it is effective at the dose tested and against the illness for which it is prescribed. In the standard procedure, Phase II clinical trials gauge efficacy, and Phase III trials confirm it. of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling. drug. read more »

There is a network of workers located at AIDS Councils and PLHIVPerson (or people) Living with HIV. This term is now preferred over the older PLWHAPerson (or People) Living with HIV/AIDS.. organisations around Australasia who understand the variety of treatment issues faced by positive people. We call them the Treataware Outreach Network.

ADRIAN OGIER thought it was time we shared some of their stories. read more »

As part of Mardi Gras Festival celebrations this year, NAPWA's Treataware is putting on two CHIN WAG chat shows, one in the east of town, at the Cambridge Hotel in Surry Hills, and one in the west, at the Clarence, in Petersham. Positive people, their friends, partners, carers and other interested parties are all welcome. read more »

This Treataware fact sheet explains the issues for people with HIV/AIDS around coinfection with hepatitis A, B & C, including ways to minimise risk and treatment options. read more »

From 1 January 2010 and for the cost of a single PBS[Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs.] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. script, Australians will be able to access Atripla, the first HIV medication to combine three treatments in a single once-a-day tablet. read more »

NAPWA’s Treataware project recently presented a poster at the 9th AIDS Impact Conference in Gaborone, Botswana. read more »

NAPWA’s continuing partnership with Igat HopeOrganisation representing people living with HIV/AIDS in Papua New Guinea. ('Igat Hope' means 'There is hope' in Tok Pisin, the national language of PNGPapua New Guinea). in PNGPapua New Guinea took another leap forward with several training days addressing HIV peer education in Port Moresby on 20-21 May. read more »

NAPWA has produced this guide to help HIV-positive Australians make the best decisions they can about their health, care and treatment. read more »

This Treataware fact sheet explains the current knowledge about cardiovascular (heart) disease risk in people living with HIV/AIDS, and some strategies for minimising risk. read more »